Marty Glick

Marty Glick is currently in his 11th season with the Golden State Warriors, his ninth as special advisor to ownership. In this capacity, Glick is primarily responsible for advising ownership and helping execute major strategic initiatives, which included the financing and development of Chase Center, the team’s state-of-the-art sports and entertainment center, which opened in September 2019 in San Francisco and was recently named “Sports Facility of the Year” by the Sports Business Journal. He is also a board member and serves on the Grant committee for the Warriors Community Foundation, which has supplied over $14 million in grants to local Bay Area non-profits since 2012.

Prior to assuming his current role in the summer of 2013, Glick served two seasons as chief financial officer for the Warriors, overseeing all financial strategy, planning and accounting for the organization. He is also a minority investor.

A highly-regarded former biotech executive whose affiliations have a history of innovative success, Glick has accumulated a wealth of experience as a prominent financial figure for several large biotech businesses during his career. He spent more than a decade (1987-1997) at Genentech of South San Francisco, where he most recently served as vice president of finance. He also served as executive vice president and chief financial officer of Theravance, a Bay Area-based drug discovery company, for seven years (1998-2005) and was a co-founder and board member of Eyetech Pharmaceuticals.

Additionally, Glick was co-founder and chairman of the board of PEAK Surgical – an innovative private medical device company – and his résumé also includes a seven-plus year stint as the chair of the Biotech Tax and Finance Committee.

A native of Chicago, Glick earned his MBA in Finance at Kellogg School of Management at Northwestern University, his Bachelor of Science in Business Administration (BSBA) in Accounting at Creighton University and is also a CPA and Chartered Accountant

(Ontario, Canada).